These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 31588590)
1. The emergence of non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI in patients with chronic hepatitis C. Toyoda H; Tada T; Yasuda S; Mizuno K; Sone Y; Kaneoka Y; Maeda A; Akita T; Tanaka J; Kumada T Aliment Pharmacol Ther; 2019 Dec; 50(11-12):1232-1238. PubMed ID: 31588590 [TBL] [Abstract][Full Text] [Related]
2. Identification of the suitable candidates for EOB-MRI with the high risk of the presence of non-hypervascular hypointense nodules in patients with HCV infection. Toyoda H; Yasuda S; Shiota S; Sone Y; Maeda A; Kaneoka Y; Kumada T; Tanaka J Eur Radiol; 2022 Jul; 32(7):5016-5023. PubMed ID: 35142900 [TBL] [Abstract][Full Text] [Related]
3. Pretreatment non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of hepatocellular carcinoma development after sustained virologic response in HCV infection. Toyoda H; Yasuda S; Shiota S; Sone Y; Maeda A; Kaneoka Y; Kumada T; Tanaka J Aliment Pharmacol Ther; 2021 Jun; 53(12):1309-1316. PubMed ID: 33896023 [TBL] [Abstract][Full Text] [Related]
4. The impact of HCV eradication by direct-acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study. Toyoda H; Kumada T; Tada T; Mizuno K; Sone Y; Akita T; Tanaka J; Johnson PJ Liver Int; 2019 Mar; 39(3):448-454. PubMed ID: 30312003 [TBL] [Abstract][Full Text] [Related]
5. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma. Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990 [TBL] [Abstract][Full Text] [Related]
6. Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC. Toyoda H; Kumada T; Tada T; Sone Y; Maeda A; Kaneoka Y Hepatol Int; 2015 Jan; 9(1):84-92. PubMed ID: 25788383 [TBL] [Abstract][Full Text] [Related]
7. Impact of previously cured hepatocellular carcinoma (HCC) on new development of HCC after eradication of hepatitis C infection with non-interferon-based treatments. Toyoda H; Kumada T; Tada T; Mizuno K; Sone Y; Kaneoka Y; Maeda A; Akita T; Tanaka J Aliment Pharmacol Ther; 2018 Sep; 48(6):664-670. PubMed ID: 30047149 [TBL] [Abstract][Full Text] [Related]
8. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma. Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908 [TBL] [Abstract][Full Text] [Related]
9. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral. Li XH; Huang R; Yang M; Wang J; Gao YH; Jin Q; Ma DL; Wei L; Rao HY World J Gastroenterol; 2022 May; 28(20):2214-2226. PubMed ID: 35721884 [TBL] [Abstract][Full Text] [Related]
10. Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy. Toyoda H; Kumada T; Tada T; Niinomi T; Ito T; Sone Y; Kaneoka Y; Maeda A J Hepatol; 2013 Jun; 58(6):1174-80. PubMed ID: 23376360 [TBL] [Abstract][Full Text] [Related]
11. Long-term persistence of hepatocarcinogenic potential of a non-hypervascular hypointense nodule on EOB-MRI after the eradication of hepatitis C virus. Toyoda H; Yasuda S; Shiota S; Kumada T Hepatol Res; 2022 Jan; 52(1):128-132. PubMed ID: 34472681 [TBL] [Abstract][Full Text] [Related]
12. Association between non-hypervascular hypointense nodules on gadoxetic acid-enhanced MRI and liver stiffness or hepatocellular carcinoma. Hwang JA; Kang TW; Kim YK; Kim SH; Paik YH; Ha SY; Kim S Eur J Radiol; 2017 Oct; 95():362-369. PubMed ID: 28987693 [TBL] [Abstract][Full Text] [Related]
13. Surgical Indications for Hepatocellular Carcinoma with Non-hypervascular Hypointense Nodules Detected by Gd-EOB-DTPA-Enhanced MRI. Takeishi K; Yoshizumi T; Itoh S; Yugawa K; Yoshiya S; Toshima T; Harada N; Ikegami T; Nishie A; Mori M Ann Surg Oncol; 2020 Sep; 27(9):3344-3353. PubMed ID: 32246316 [TBL] [Abstract][Full Text] [Related]
14. Progression of Hepatic Hypovascular Nodules with Hypointensity in the Hepatobiliary Phase of Gd-EOB-DTPA-enhanced MRI in Hepatocellular Carcinoma Cases. Saitoh T; Sato S; Yazaki T; Tobita H; Miyake T; Ishihara S; Katsube T; Kitagaki H; Kinoshita Y Intern Med; 2018 Jan; 57(2):165-171. PubMed ID: 29033416 [TBL] [Abstract][Full Text] [Related]
15. Direct-Acting Antiviral Agents Reduce the Risk of Malignant Transformation of Hepatobiliary Phase-Hypointense Nodule without Arterial Phase Hyperenhancement to Hepatocellular Carcinoma on Gd-EOB-DPTA-Enhanced Imaging in the Hepatitis C Virus-Infected Liver. Shimizu Y; Arai K; Yamashita T; Yamashita T; Shimakami T; Kawaguchi K; Kitamura K; Sakai Y; Mizukoshi E; Honda M; Kitao A; Kozaka K; Kobayashi S; Kaneko S Liver Cancer; 2020 Jun; 9(3):261-274. PubMed ID: 32647630 [TBL] [Abstract][Full Text] [Related]
16. Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study. Inoue T; Hyodo T; Korenaga K; Murakami T; Imai Y; Higaki A; Suda T; Takano T; Miyoshi K; Koda M; Tanaka H; Iijima H; Ochi H; Hirooka M; Numata K; Kudo M J Gastroenterol; 2016 Feb; 51(2):144-52. PubMed ID: 26373860 [TBL] [Abstract][Full Text] [Related]
17. High-risk nodules detected in the hepatobiliary phase of Gd-EOB-DTPA-enhanced MR imaging in cirrhosis or chronic hepatitis: incidence and predictive factors for hypervascular transformation, preliminary results. Higaki A; Ito K; Tamada T; Teruki S; Yamamoto A; Higashi H; Kanki A; Sato T; Noda Y J Magn Reson Imaging; 2013 Jun; 37(6):1377-83. PubMed ID: 23172841 [TBL] [Abstract][Full Text] [Related]
18. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B. Lee JH; Kim YR; Lee GM; Ryu JH; Cho EY; Lee YH; Yoon KH Eur J Radiol; 2018 May; 102():95-101. PubMed ID: 29685552 [TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging. Pan S; Wang XQ; Guo QY World J Gastroenterol; 2018 May; 24(18):2024-2035. PubMed ID: 29760545 [TBL] [Abstract][Full Text] [Related]
20. Non-Hypervascular Hypointense Nodules at Gadoxetic Acid MRI: Hepatocellular Carcinoma Risk Assessment with Emphasis on the Role of Diffusion-Weighted Imaging. Briani C; Di Pietropaolo M; Marignani M; Carbonetti F; Begini P; David V; Iannicelli E J Gastrointest Cancer; 2018 Sep; 49(3):302-310. PubMed ID: 28547117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]